| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2322245-42-9 | SRI-37330 |
≥98% | | 询价 |
| 2 | 2226521-64-6 | FM-479 |
≥98% | | 询价 |
| 3 | 852225-20-8 | WAY 647802 |
≥98% | | 询价 |
| 4 | 2095596-11-3 | (S)-ZINC-3573 |
≥98% | | 询价 |
| 5 | 3258-02-4 | EIDD-1931(Beta-d-N4-hydroxycytidine NHC) |
≥98% | | 询价 |
| 6 | | 2',3'-cGAMP sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 1652629-23-6 | GSK484 free base |
≥98% | | 询价 |
| 8 | 1228585-88-3 | Vesatolimod(GS-9620) |
≥98% | | 询价 |
| 9 | 87134-87-0 | SCH-23390 maleate |
≥98% | | 询价 |
| 10 | 118457-14-0 | Nebivolol(R 065824) |
≥98% | | 询价 |
| 11 | | Decamethonium sulfate |
≥98% | | 询价 |
| 12 | 90093-40-6 | Suprastat |
≥98% | | 询价 |
| 13 | 1797983-09-5 | GSK J4 HCl |
≥98% | | 询价 |
| 14 | 1222800-79-4 | ML324 |
≥98% | | 询价 |
| 15 | 203192-01-2 | MN58b |
≥98% | | 询价 |
| 16 | 1675203-82-3 | BMS-200 |
≥98% | | 询价 |
| 17 | 1675201-90-7 | BMS-8 |
≥98% | | 询价 |
| 18 | 1675201-83-8 | BMS-1 |
≥98% | | 询价 |
| 19 | 2242952-69-6 | BMS-986299 |
≥98% | | 询价 |
| 20 | 2204289-54-1 | SHMT-IN-2 HCl |
≥98% | | 询价 |
| 21 | 561-56-8 | Gibberellin A5 |
≥98% | | 询价 |
| 22 | 144096-47-9 | Agistatin D |
≥98% | | 询价 |
| 23 | 1452458-70-6 | FPI-1465 |
≥98% | | 询价 |
| 24 | 1170694-29-7 | RJ-34 |
≥98% | | 询价 |
| 25 | 2237957-26-3 | STAT3-IN-8 |
≥98% | | 询价 |
| 26 | 2237955-91-6 | STAT3-IN-7 |
≥98% | | 询价 |
| 27 | 153821-50-2 | Aquastatin A |
≥98% | | 询价 |
| 28 | 1454902-97-6 | Elevenostat |
≥98% | | 询价 |
| 29 | 1205538-83-5 | Calpinactam |
≥98% | | 询价 |
| 30 | 2751721-40-9 | AZ5576 |
≥98% | | 询价 |
| 31 | 2499491-04-0 | STAT3-IN-10 |
≥98% | | 询价 |
| 32 | 1026785-59-0 | cis-Lomibuvir |
≥98% | | 询价 |
| 33 | 126775-74-4 | Himastatin |
≥98% | | 询价 |
| 34 | 2452118-54-4 | VIM-2-IN-1 |
≥98% | | 询价 |
| 35 | 265989-49-9 | 4-Hydroxy Atorvastatin lactone-d5 |
≥98% | | 询价 |
| 36 | 265989-45-5 | 4-Hydroxy Atorvastatin-d5 calcium |
≥98% | | 询价 |
| 37 | 2130853-04-0 | Belinostat acid-d5 |
≥98% | | 询价 |
| 38 | 2043026-13-5 | Roxadustat-d5 |
≥98% | | 询价 |
| 39 | 1285539-74-3 | Febuxostat-d7 |
≥98% | | 询价 |
| 40 | 1185237-51-7 | Panobinostat-d4 HCl |
≥98% | | 询价 |
| 41 | 265989-50-2 | Ortho-hydroxy atorvastatin lactone-d5 |
≥98% | | 询价 |
| 42 | 2712343-38-7 | Raltegravir-d4 |
≥98% | | 询价 |
| 43 | 1801709-41-0 | Daclatasvir-d6 |
≥98% | | 询价 |
| 44 | | Givinostat impurity 1-d10 HCl |
≥98% | | 询价 |
| 45 | 1356934-56-9 | Ertapenem-d4 disodium |
≥98% | | 询价 |
| 46 | | Pravastatin-13C,d3 sodium |
≥98% | | 询价 |
| 47 | | LQVTDSGLYRCVIYHPP TFA |
≥98% | | 询价 |
| 48 | | RAR ligand 1(Ch55-O-C3-carbaldehyde) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | | PROTAC IAP binding moiety 2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | | PROTAC IAP binding moiety 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | | PROTAC BRD9-binding moiety 1 hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | | E3 ligase Ligand-Linker Conjugates 32 hydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | | E3 ligase Ligand 1 dihydrochloride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | | E3 ligase Ligand 13 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | | CDK9 Antagonist-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | | PROTAC B-Raf degrader 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | | PROTAC CRBN Degrader-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | | PROTAC FAK degrader 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | | PROTAC ER Degrader-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | | PROTAC ERαDegrader-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com